Cancer Research · 2023 · 56 citations · 44 references
MedicineCancer BiologyOncologyChemotherapyMetastasisMolecular OncologyCancer Cell SignalingCancer ProgressionChemotherapy In Hematologic MalignanciesHematologic Malignancy TherapyMetastatic Signaling PathwaysTargeted TherapyAcute Myeloid Leukemia BiologyAcute Myeloid Leukemia ProgressionAcute Myeloid Leukemia TherapyAcute Myeloid Leukemia TreatmentExtramedullary RelapseHematologic NeoplasiaRelapsed Acute Myeloid LeukemiaTherapeutic Resistance Mechanisms
Identifying mechanisms underlying relapse is a major clinical issue for effective cancer treatment. The emerging understanding of the importance of metastasis in hematologic malignancies suggests that it could also play a role in drug resistance and relapse in acute myeloid leukemia (AML). In a cohort of 1,273 AML patients, we uncovered that the multifunctional scavenger receptor CD36 was positively associated with extramedullary dissemination of leukemic blasts, increased risk of relapse after intensive chemotherapy, and reduced event-free and overall survival. CD36 was dispensable for lipid uptake but fostered blast migration through its binding with thrombospondin-1. CD36-expressing blasts, which were largely enriched after chemotherapy, exhibited a senescent-like phenotype while maintaining their migratory ability. In xenograft mouse models, CD36 inhibition reduced metastasis of blasts and prolonged survival of chemotherapy-treated mice. These results pave the way for the development of CD36 as an independent marker of poor prognosis in AML patients and a promising actionable target to improve the outcome of patients. SIGNIFICANCE: CD36 promotes blast migration and extramedullary disease in acute myeloid leukemia and represents a critical target that can be exploited for clinical prognosis and patient treatment.
44
David Grimwade, Robert K. Hills, Anthony V. Moorman et al. · Blood · 2010 · 2K citations · Full text
Life Sciences, Hematology, Oncology +16
Functional genomic landscape of acute myeloid leukaemia
Jeffrey Tyner, Cristina E. Tognon, Daniel Bottomly et al. · Nature · 2018 · 1.5K citations · Full text
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual, Alexandra Avgustinova, Stefania Mejetta et al. · Nature · 2016 · 1.4K citations
Medicine, Cancer Biology, Oncology +14
CD36 is a receptor for oxidized low density lipoprotein
Gerda Endemann, Lawrence W. Stanton, Kelley S. Madden et al. · Journal of Biological Chemistry · 1993 · 1.3K citations · Full text